Your browser doesn't support javascript.
loading
Assessing the capability of massively parallel sequencing for opportunistic pharmacogenetic screening.
Ng, David; Hong, Celine S; Singh, Larry N; Johnston, Jennifer J; Mullikin, James C; Biesecker, Leslie G.
Afiliação
  • Ng D; Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Hong CS; Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Singh LN; Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Johnston JJ; Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Mullikin JC; NIH Intramural Sequencing Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Biesecker LG; Comparative Genomics and Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
Genet Med ; 19(3): 357-361, 2017 03.
Article em En | MEDLINE | ID: mdl-27537706

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Análise de Sequência com Séries de Oligonucleotídeos / Testes Farmacogenômicos Tipo de estudo: Diagnostic_studies / Guideline / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Análise de Sequência com Séries de Oligonucleotídeos / Testes Farmacogenômicos Tipo de estudo: Diagnostic_studies / Guideline / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article